HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia (Q43811445)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2001

Language	Label	Description	Also known as
English	HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia	scientific article published in December 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

author name string

Liang JS

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Distler O

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Cooper DA

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Jamil H

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Deckelbaum RJ

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ginsberg HN

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sturley SL

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Nature Medicine

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1327-1331

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe premature coronary artery disease with protease inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoproteins and the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoprotein B100 has a prolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence.

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV protease inhibitors stimulate hepatic triglyceride synthesis.

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Very-low-density lipoprotein assembly and secretion

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular assembly of VLDL: two major steps in separate cell compartments

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Mouse Models of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

A risk-benefit assessment of HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial infarction in HIV-infected men receiving protease inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a)

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of a dispersion of cholesterol in Triton WR-1339 on acyl CoA: cholesterol acyltransferase in rat liver microsomes

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1038%2FNM1201-1327

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NM1201-1327

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43811445&oldid=2209192216"